Prime Medicine, Inc. (PRME)
2.98
-0.01
(-0.33%)
USD |
NASDAQ |
Oct 02, 16:00
3.00
+0.02
(+0.67%)
After-Hours: 20:00
Prime Medicine Net Income (Quarterly) : -42.11M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -42.11M |
| March 31, 2026 | -49.12M |
| December 31, 2025 | -46.08M |
| September 30, 2025 | -50.58M |
| June 30, 2025 | -52.59M |
| March 31, 2025 | -51.89M |
| December 31, 2024 | -42.28M |
| September 30, 2024 | -52.52M |
| June 30, 2024 | -55.33M |
| March 31, 2024 | -45.76M |
| December 31, 2023 | -65.64M |
| September 30, 2023 | -50.71M |
| Date | Value |
|---|---|
| June 30, 2023 | -42.38M |
| March 31, 2023 | -39.40M |
| December 31, 2022 | -39.28M |
| September 30, 2022 | -29.35M |
| June 30, 2022 | -29.35M |
| March 31, 2022 | -23.84M |
| December 31, 2021 | -62.91M |
| September 30, 2021 | -16.41M |
| June 30, 2021 | 0.616M |
| March 31, 2021 | -86.66M |
| December 31, 2020 | -2.565M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -122.68M |
| Twist Bioscience Corp. | -35.05M |
| Intellia Therapeutics, Inc. | -106.63M |
| Q32 Bio, Inc. | -8.946M |
| Revolution Medicines, Inc. | -644.37M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.154M |
| Total Expenses (Quarterly) | 43.26M |
| EPS Diluted (Quarterly) | -0.2376 |
| Enterprise Value | 556.00M |
| Gross Profit Margin (Quarterly) | -54.68% |
| Profit Margin (Quarterly) | -3.65K% |
| Earnings Yield | -36.43% |
| Normalized Earnings Yield | -36.70 |